# BAYER PHARMA, AG, Berlin, Germany – FDA Inspections

Source: https://www.keypedia.com/companies/bayer-pharma-ag/28300a22-c506-4b1a-9052-6fc4e7170384

> Inspection records and compliance data for BAYER PHARMA, AG in Berlin. 10 FDA inspections on record, 2 Form 483s, last inspected June 06, 2024.

---

## Details

- Name: BAYER PHARMA, AG
- FEI Number: 3002808086
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: Mullerstr. 170-178
- City: Berlin
- Country Name: Germany
- Address: Mullerstr. 170-178, Berlin, Germany
- Country: Germany

## Related Documents

- [FDA Inspection 1282736 - BAYER PHARMA, AG - 2024-06-06](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/1d238dca-b4e7-4c8f-8c8c-40de3cf1da86) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2024
- FDA Inspection 1239178 - BAYER PHARMA, AG - 2021-08-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 27, 2021
- [FDA Inspection 1102816 - BAYER PHARMA, AG - 2019-09-24](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/f4d6e717-a64d-42ca-931d-40fe4ad01598) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2019
- [FDA Inspection 1023408 - BAYER PHARMA, AG - 2017-07-03](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/4cad4b59-7cd0-472e-b6f8-749df0c15721) — source: FDA, date: July 3, 2017
- [FDA Inspection 1001127 - BAYER PHARMA, AG - 2017-01-24](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/5e47f2e1-951b-482a-ad43-bb89fe81b130) — classification: No Action Indicated (NAI), source: FDA, date: January 24, 2017
- [FDA Inspection 889209 - BAYER PHARMA, AG - 2014-05-13](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/62dcd89d-3755-4ff0-bfd0-1cd68e1ec209) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 13, 2014
- FDA Inspection 876478 - BAYER PHARMA, AG - 2014-04-17 — classification: No Action Indicated (NAI), source: FDA, date: April 17, 2014
- FDA Inspection 803657 - BAYER PHARMA, AG - 2012-09-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2012
- FDA Inspection 716641 - BAYER PHARMA, AG - 2010-11-19 — classification: No Action Indicated (NAI), source: FDA, date: November 19, 2010
- FDA Inspection 704427 - BAYER PHARMA, AG - 2010-11-16 — classification: No Action Indicated (NAI), source: FDA, date: November 16, 2010

## Related Companies

- [Zhejiang Yongning Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-yongning-pharmaceutical-co-ltd/70a5bf94-4ed4-42f8-9efe-e4917c7aae66)
- [Baxter Healthcare S.A.](https://www.keypedia.com/companies/baxter-healthcare-sa/027068ec-1edf-444c-aabb-c9da8dbf31f0)
- [Baxter, S.A. De C.V.](https://www.keypedia.com/companies/baxter-sa-de-cv/f8b22a08-81dc-42b5-a63e-55b31afb5428)
- [N.V. Organon (MSD)](https://www.keypedia.com/companies/nv-organon-msd/dc305126-e2d1-4dba-8538-f815391f40a5)
- [B Braun Melsungen Ag- Aktiengesellschaft](https://www.keypedia.com/companies/b-braun-melsungen-ag-aktiengesellschaft/1a2b15e4-288a-426d-a9d6-7b7bbf698315)
- [Solupharm Pharmazeutische Erzeugnisse Gmbh](https://www.keypedia.com/companies/solupharm-pharmazeutische-erzeugnisse-gmbh/dd3d4b95-d76b-4afa-b430-f1dee1ebb184)
- [Rotop Pharmaka GmbH](https://www.keypedia.com/companies/rotop-pharmaka-gmbh/2e70dc22-0e67-419c-9336-09aac288a049)
- [Fine Chemicals Corporation](https://www.keypedia.com/companies/fine-chemicals-corporation/730ca996-9341-4015-b149-6a580d631c61)
- [Faes Farma, S.A.](https://www.keypedia.com/companies/faes-farma-sa/59213665-501b-4e8f-8c37-247c01ecdb2c)
- [LEK d.d.](https://www.keypedia.com/companies/lek-dd/49b1b882-f72b-4d83-b4b6-d6e117f97274)